Press release
RORgamma Modulators 2016: A Comparative Analysis Of The Landscape Of RORgamma Antagonists And Agonists
Retinoic acid-related orphan nuclear receptor gamma (RORgamma) is a hot, but difficult-to-drug target. More than 30 companies are active in drug discovery and development. Technology companies with expertise in discovery of drugs targeting nuclear hormone receptors are preferred partners of Big Pharma and Biotech companies if they have identified novel scaffolds of RORgamma antagonists. More than ten such technology-pharma partnerships have been founded and already lead to first successes. Three RORgamma antagonists (inverse agonists) are already in clinical development and more to follow in 2016 and thereafter.
The report explains the scientific rationale for discovering antagonists of RORgamma for treatment of autoimmune and inflammatory diseases, but also of agonists of RORgamma for treatment of cancer. Clinical as well as non-clinical data for target validation of RORgamma are provided. Lead and up-side indications for development including the key product profile are discussed. Potential safety concerns for novel RORgamma modulators were identified.
Request For The Sample Copy Of This Report @ http://www.marketresearchreports.biz/sample/sample/556098
Drug discovery approaches of technology and pharmaceutical companies are shown regarding strategies in partnering as well as in technologies applied for structure-based drug discovery. Based on the experience in the past, estimates of the required time from start of a discovery program of RORgamma modulators until entry into human studies are calculated. The competitive landscape of RORgamma modulator development and discovery projects is analyzed and the profiles of companies elaborated, separately for unpartnered technology or pharmaceutical companies and for partnerships between technology and pharmaceutical companies.
The report provides an understanding of:
- The target RORgamma
- Clinical and non-clinical target validation
- Clinical lead and up-side indications
- Drug discovery strategies and technologies
- Commercial value of drug discovery collaborations
- R&D timelines from start of screening to first-in-human studies
- Competitive landscape of RORgamma antagonists
- Agonists of RORgamma for cancer
- Profiles of unpartnered technology companies and lead projects
- R&D Partnerships and their discovery approaches and lead molecules
- Unpartnered pharmaceutical companies and their programs
MarketResearchReports.biz supports your business intelligence needs with over 100,000 market research reports, company profiles, data books, and regional market data sheets in its repository. Our document database is updated by the hour, which means that you always have access to fresh data spanning over 300 industries and their sub-segments.
State Tower
90 State Street, Suite 700
Albany, NY 12207
United States
Toll Free: 866-997-4948
(USA-CANADA)
Tel: +1-518-621-2074
E: sales@marketresearchreports.biz
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release RORgamma Modulators 2016: A Comparative Analysis Of The Landscape Of RORgamma Antagonists And Agonists here
News-ID: 565016 • Views: …
More Releases from MarketResearchReports.biz
Hydro-flyers Market: Moving Towards a Brighter Future
A hydro-flyer is an adventure sporting device which uses the propulsion of water jet technology to create continuous flight movement, where the lift and movement are controlled by the flyer. Hydro-flyers sporting devices make use of the flow of water power to drive the flyer to reach soaring heights. The rise in water sporting facilities is one of the major factors that promote the growth and demand for hydro-flyers in…
Outdoor Floodlights: Technology and Market Dynamics
Outdoor floodlights is a reliable, highly efficient, and economical solution for a wide range of outdoor applications. These lights are resistant to temperature fluctuations and they remain stable even in extreme climatic conditions. Unlike the traditional lights, floodlights remain stable and functional even in harsh climatic conditions. This makes them ideal for use in any climate and any outdoor application. Outdoor floodlights save a significant amount of energy and consume…
Snow Helmets Market Future Prospects and Regional Outlook
Riders are riding faster and getting bolder day by day. Hence, safety equipment need to be updated as per the requirement and changing time. Earlier, helmets were primarily used by extreme skiers and racers. They were used only on slopes. However, later, the use of helmets was made compulsory. Earlier, bulky black helmets were used by riders, which are outdated at present. Currently, new stylish helmets that can match with…
Predictions for 2019: Global Sparkling Water Dispensers Industry Is Set to Boom
Sparkling water dispensers are equipment used for dispensing carbonated water. These dispensers mix the still, filtered water with carbon dioxide before dispensing. Sparkling water dispensers are mostly used in households and commercial establishments such as amusement parks, hotels, restaurants, and sports arenas. A sparkling water dispenser has separate outlets for hot water and cold water. The hot water outlet does not require a separate filtration process. However, cold water is…
More Releases for RORgamma
Nuclear Receptor ROR-Gamma Market Report 2018: Segmentation by Product (VPR66, I …
Global Nuclear Receptor ROR-Gamma market research report provides company profile for Brickell Biotech, Inc., BristolMyers Squibb Company, Celgene Corporation, Genentech, Inc., Genfit SA, GlaxoSmithKline Plc, 4SC AG, Advinus Therapeutics Ltd., Arrien Pharmaceuticals, LLC, Aurigene Discovery Technologies Limited, Biogen, Inc. and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of…
RORgamma Modulators: A comparative analysis of the landscape of RORgamma antagon …
Latest industry research report on: RORgamma Modulators Market | Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts
Download Sample copy of this Report at :http://www.marketresearchreports.biz/sample/sample/556098
Retinoic acid-related orphan nuclear receptor gamma (RORgamma) is a hot, but difficult-to-drug target. More than 30 companies are active in drug discovery and development. Technology companies with expertise in discovery of drugs targeting nuclear hormone receptors are preferred partners of Big Pharma and…
RORgamma Modulators 2016: A comparative analysis of the landscape of RORgamma an …
Researchmoz added Most up-to-date research on "RORgamma Modulators 2016: A comparative analysis of the landscape of RORgamma antagonists and agonists" to its huge collection of research reports.
Retinoic acid-related orphan nuclear receptor gamma (RORgamma) is a hot, but difficult-to-drug target. More than 30 companies are active in drug discovery and development. Technology companies with expertise in discovery of drugs targeting nuclear hormone receptors are preferred partners of Big Pharma and Biotech…
New Market Research Report Studies State Of RORgamma Modulators 2016
MarketResearchReports.biz has announced that it now carries a report titled, ‘RORgamma Modulators 2016: A Comparative Analysis Of The Landscape Of RORgamma Antagonists And Agonists.’ The report, prepared by a team of experts in the field, will serve as tool that enables companies with business interests in this area to make better informed decisions.
RAR-related orphan receptor gamma (ROR?) is classified as a protein and it is encoded by the gene, RAR-related…
RORgamma Modulators 2016: A comparative analysis of the landscape of RORgamma an …
Researchmoz added Most up-to-date research on "RORgamma Modulators 2016: A comparative analysis of the landscape of RORgamma antagonists and agonists" to its huge collection of research reports.
"RORgamma Modulators 2016: A comparative analysis of the landscape of RORgamma Antagonists and Agonists"
Retinoic acid-related orphan nuclear receptor gamma (RORgamma) is a hot, but difficult-to-drug target. More than 30 companies are active in drug discovery and development. Technology companies with expertise in discovery of…
RORgamma Modulators 2016: A comparative analysis of the landscape of RORgamma an …
"RORgamma Modulators 2016: A comparative analysis of the landscape of RORgamma Antagonists and Agonists"
Retinoic acid-related orphan nuclear receptor gamma (RORgamma) is a hot, but difficult-to-drug target. More than 30 companies are active in drug discovery and development. Technology companies with expertise in discovery of drugs targeting nuclear hormone receptors are preferred partners of Big Pharma and Biotech companies if they have identified novel scaffolds of RORgamma antagonists. More than ten…
